Skip to main content

and
  1. Article

    Open Access

    Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia

    FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is a common mutation type in acute myeloid leukemia (AML) and is usually associated with poor patient prognosis. With advancements in molecular...

    Chuhong Hu, Yvyin Zhang, Jie Yang, Yanli Xu in Cell Communication and Signaling (2024)

  2. Article

    Augmentation of transgene-encoded protein after neonatal injection of adeno-associated virus improves hepatic copy number without immune responses

    Achieving persistent expression is a prerequisite for genetic therapies for inherited metabolic enzymopathies. Such disorders potentially could be treated with gene therapy shortly after birth to prevent patho...

    Denise S. Tai, Chuhong Hu, Elizabeth H. Kim, Gerald S. Lipshutz in Pediatric Research (2015)